Fibralign Corporation SBIR Phase II Award, February 2019

A SBIR Phase II contract was awarded to Fibralign Corporation in February, 2019 for $996,609.0 USD from the U.S. Department of Defense and Defense Health Agency.

Overview Structured Data Issues Contributors Activity

sbir.gov/node/1843453

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

Fibralign Corporation

Government Agency

U.S. Department of Defense

Government Branch

Defense Health Agency

Award Type

SBIR0

Contract Number (US Government)

W81XWH19C00210

Award Phase

Phase II0

Award Amount (USD)

996,6090

Date Awarded

February 7, 2019

End Date

July 6, 2021

Abstract

To address the scarcity of effective treatments for volumetric muscle loss injuries, we propose a novel aligned multilumen nanofibrillar collagen scaffold loaded with Hepatocyte Growth Factor (HGF) modified messenger RNA (mmRNA) to direct functional muscl